Ken Griffin Meira G Tx Holdings PLC Put Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$3.88 - $5.23 $1,164 - $1,569	300 Added 0.98%	31,000 $129,000
Q2 2024 Aug 14, 2024	BUY	$4.21 - $5.81 $41,258 - $56,937	9,800 Added 46.89%	30,700 $129,000
Q1 2024 May 15, 2024	SELL	$5.78 - $7.33 $215,594 - $273,409	-37,300 Reduced 64.09%	20,900 $126,000
Q4 2023 Feb 14, 2024	BUY	$3.6 - $7.15 $145,440 - $288,860	40,400 Added 226.97%	58,200 $408,000
Q3 2023 Nov 14, 2023	SELL	$4.79 - $7.19 $56,522 - $84,842	-11,800 Reduced 39.86%	17,800 $87,000
Q2 2023 Aug 14, 2023	BUY	$5.19 - $8.07 $61,761 - $96,033	11,900 Added 67.23%	29,600 $198,000
Q1 2023 May 15, 2023	BUY	$5.04 - $8.6 $77,112 - $131,580	15,300 Added 637.5%	17,700 $91,000
Q4 2022 Feb 14, 2023	SELL	$5.8 - $8.98 $106,140 - $164,334	-18,300 Reduced 88.41%	2,400 $15,000
Q3 2022 Nov 14, 2022	BUY	$7.55 - $11.25 $156,285 - $232,875	20,700 New	20,700 $174,000

100

45.4M

19.2K

31K

Ticker MGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,010,700
Market Cap $288M
Description
MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative dise...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.